Donald Hooker
Stock Analyst at Keybanc
(2.66)
# 1,970
Out of 4,670 analysts
82
Total ratings
58.43%
Success rate
11.32%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $10.62 | +841.62% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $195.77 | +99.21% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $163.59 | +3.92% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $201.82 | +43.69% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $19.87 | +267.39% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $5.70 | +531.58% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $8.10 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $216.58 | +62.99% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $104.25 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $73.09 | +14.93% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $11.25 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $239.67 | -29.07% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $214.25 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.35 | +3,307.41% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $22.84 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $337.75 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $10.62
Upside: +841.62%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $195.77
Upside: +99.21%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $163.59
Upside: +3.92%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $201.82
Upside: +43.69%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $19.87
Upside: +267.39%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $5.70
Upside: +531.58%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $8.10
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $216.58
Upside: +62.99%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $104.25
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $73.09
Upside: +14.93%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $11.25
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $239.67
Upside: -29.07%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $214.25
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.35
Upside: +3,307.41%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $22.84
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $337.75
Upside: -